The manifestation of oral mucositis in COVID-19 patients: A case-series

RIAD, Abanoub, Islam KASSEM, Mai BADRAH and Miloslav KLUGAR. The manifestation of oral mucositis in COVID-19 patients: A case-series. Dermatologic Therapy. Hoboken: Wiley, 2020, vol. 33, No 6, p. 1-3. ISSN 1396-0296. Available from: https://dx.doi.org/10.1111/dth.14479.

Basic information

• Original name: The manifestation of oral mucositis in COVID-19 patients: A case-series
• Authors: RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Islam KASSEM (818 Egypt), Mai BADRAH (818 Egypt) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution).
• Edition: Dermatologic Therapy, Hoboken, Wiley, 2020, 1396-0296.

Other information

• Original language: English
• Type of outcome: Article in a journal
• Field of Study: 30216 Dermatology and venereal diseases
• Country of publisher: United States of America
• Confidentiality degree: is not subject to a state or trade secret
• WWW: URL
• Impact factor: Impact factor: 2.851
• RIV identification code: RIV/00216224:14110/20:00116797
• Organization unit: Faculty of Medicine
• Doi: http://dx.doi.org/10.1111/dth.14479
• UT WoS: 000587315600001
• Keywords in English: Oral Mucositis; COVID-19
• Tags: 14119612, 14119613, rivok

Abstract

We have read with great interest the correspondence of Kahraman et al (2020) on the emergence of oral mucosal changes adjacent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; hereby we demonstrate the characteristics of 13 laboratoryconfirmed coronavirus disease (COVID-19) patients with oral mucositis according to the CARE guidelines. The referenced patients sought care at our department from April to August 2020 due to generalized pain and soreness within the oral cavity related mainly to nonkeratinized mucosa without a specific cause (Table 1). All included patients had previously undergone polymerase chain reaction (PCR) testing for SARS-CoV-2, which confirmed their infection with a mean cycle threshold (Ct) value of 18.46 ± 3.8 (12-26). Their mean age was 51.08 ± 8.79 (34-62) years old, and eight of them (62.5%) were females. Regarding their COVID-19 symptoms, two patients (15.4%) had persistent fever, four (30.8%) had ageusia, and two (15.4%) had anosmia. The majority of them (69.2%) had a mild course of SARS-CoV-2 infection and were prescribed paracetamol (PCM); contrarily, four patients experienced a moderate course of infection—two patients (15.4%) were prescribed chloroquine and other two (15.4%) were prescribed dexamethasone.